Symbol Therapeutics

About

Funding history · 1 round · $3.0M total

Q&A

What is the primary focus of Symbol Therapeutics?

Symbol Therapeutics is a drug discovery company focused on developing a novel immunoregulatory therapeutic protein for the treatment of systemic lupus erythematosus and other autoimmune diseases.

What is the status of Symbol Therapeutics?

Symbol Therapeutics is currently inactive, having ceased operations in November 2025.

When was Symbol Therapeutics founded?

Symbol Therapeutics was founded in November 2021.

Where is Symbol Therapeutics headquartered?

Symbol Therapeutics is headquartered in Ness Ziona, Israel.

How much funding has Symbol Therapeutics raised in total?

Symbol Therapeutics has raised a total of $3,000,000.

When was Symbol Therapeutics' last funding round and who were the investors?

Symbol Therapeutics' last funding round was in September 2022, with investments from RMGP Biopharma Investment Fund and FutuRx.

What is the current employee count for Symbol Therapeutics?

Symbol Therapeutics has 1-10 employees.

What sector does Symbol Therapeutics primarily operate in?

Symbol Therapeutics primarily operates in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.

Sectors & technology

Tags